Fig. 3From: Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonatesThe mutation frequency in carriers and biochemical index of ASS1 and MCCC1 carriers. a The numbers of variants in carriers. b The distribution of high frequency gene mutations in carriers. c Cit concentration in ASS1 gene mutation carriers and negative control. d C4DC + C5OH concentration in MCCC1 gene mutation carriers and negative controlBack to article page